Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,080.36 +5.68 (+0.53%)

Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise ↗

October 31, 2025

Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism.

Via Stocktwits

1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore

October 31, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

Twilio Stock Rises On Q3 Earnings Beat, Raised Guidance ↗

October 30, 2025

Twilio stock rose after the software maker reported Q3 earnings that topped estimates and hiked its full-year revenue outlook.

Via Investor's Business Daily

Topics Artificial Intelligence Earnings

Cloudflare Earnings Top Estimates. Revenue Outlook Above Views. ↗

October 30, 2025

Cloudflare stock wavered after the company reported Q3 earnings that topped estimates and guidance came in slightly above views.

Via Investor's Business Daily

Topics Artificial Intelligence

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Earnings Outlook For Eli Lilly ↗

October 29, 2025

Via Benzinga

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Topics ETFs

'Our GPUs Are Everywhere’ According to CEO Jensen Huang as Nvidia Doubles Down on AI, Quantum, and 6G

October 30, 2025

Nvidia stock continues to surge higher as the AI chipmaker widens its moat significantly.

Via Barchart.com

Topics Artificial Intelligence

Eli Lilly (LLY) Stock Trades Up, Here Is Why

October 30, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the morning session after the company reported a "beat and raise" quarter.

Via StockStory

Topics Artificial Intelligence Economy Government

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera ↗

October 30, 2025

Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.

Via Investor's Business Daily

Topics Economy Government

Nvidia's $5 Trillion Milestone Turns These AI ETFs Into Hot Trades ↗

October 30, 2025

Nvidia's $5 trillion valuation record is igniting momentum across semiconductor and AI-themed ETFs as investors chase the next leg of the chip supercycle.

Via Benzinga

Topics Artificial Intelligence ETFs

Tech Titans Tumble, Alphabet Soars as Market Opens Mixed on AI Spending Jitters

October 30, 2025

The U.S. stock market opened with a palpable sense of divergence on October 30, 2025, as investors grappled with a mixed bag of quarterly earnings and forward-looking statements from the nation's...

Via MarketMinute

Topics Artificial Intelligence Economy Fraud

Eli Lilly (LLY) Q3 2025 Earnings Call Transcript ↗

October 30, 2025

Eli Lilly (LLY) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly CEO Dave Ricks Reportedly Says Company Eyeing Pain Relief Market With Weight Loss Drug Retatrutide ↗

October 30, 2025

CEO Dave Ricks told CNBC that the first study the company plans to read out for Retatrutide will be on knee pain.

Via Stocktwits

Navigating the Currents: Dow Jones Shows Resilience Amidst Fed's Caution and Geopolitical Shifts

October 30, 2025

The Dow Jones Industrial Average (DJIA) finds itself navigating a complex economic landscape as of October 30, 2025, exhibiting resilience despite a barrage of mixed signals from central bank policies,...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast ↗

October 30, 2025

Eli Lilly reported Q3 revenue of $17.6 billion, beating estimates and raising 2025 guidance as Mounjaro and Zepbound sales surged.

Via Benzinga

Unpacking the Latest Options Trading Trends in Eli Lilly ↗

October 30, 2025

Via Benzinga

Eli Lilly Delivers Strong Q3 Performance, Raises Earnings Outlook ↗

October 30, 2025

Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance.

Via Talk Markets

These S&P500 stocks are moving in today's pre-market session ↗

October 30, 2025

Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.

Via Chartmill

Eli Lilly & Co (NYSE:LLY) Q3 2025 Earnings Beat Estimates, Fueling Pre-Market Rally ↗

October 30, 2025

Eli Lilly's Q3 2025 results crushed estimates, driven by high demand for Mounjaro and Zepbound. The company raised its full-year outlook, sparking a stock rally.

Via Chartmill

Topics Earnings

Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound ↗

October 30, 2025

Shares jumped early Thursday after the drugmaker easily topped third-quarter forecasts.

Via Investor's Business Daily

Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars

October 30, 2025

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue...

Via StockStory

Understanding Market Records: Is This Sustainable Growth?

October 29, 2025

The global stock market is currently navigating an unprecedented era of record-breaking growth in late October 2025, a phenomenon largely orchestrated by the remarkable performance and pervasive...

Via TokenRing AI

Topics Artificial Intelligence Economy Fraud

Nvidia Shatters Records: AI Powerhouse Hits $5 Trillion Market Cap, Reshaping Global Economy

October 29, 2025

In a historic moment for the technology and financial worlds, Nvidia Corporation (NASDAQ: NVDA) officially achieved an unprecedented $5 trillion market capitalization on Wednesday, October 29, 2025....

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

Eli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart ↗

October 29, 2025

Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide.

Via Benzinga

Topics Artificial Intelligence

Nvidia Shatters Records with $5 Trillion Market Cap, Cementing AI Revolution Leadership

October 29, 2025

Santa Clara, CA – October 29, 2025 – In a historic moment for the technology sector, Nvidia (NASDAQ: NVDA) has officially achieved an unprecedented $5 trillion market capitalization, becoming the first...

Via MarketMinute

Topics Artificial Intelligence Economy

Nvidia's 2 Surprises; NVDA Soars On Trump-Fueled Hopes of China Blackwell Sales; Fed In Focus ↗

October 29, 2025

Two Nvidia Shockers Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA).

Via Benzinga

Topics Economy

Nvidia's AI Reign: Fueling Market Gains and Forging a New Industrial Revolution

October 29, 2025

Nvidia (NASDAQ: NVDA) stands as the undisputed titan of the artificial intelligence (AI) era, its stock performance a primary catalyst for the recent, unprecedented surge in global financial markets....

Via MarketMinute

Topics Artificial Intelligence Economy Government

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.